We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

18 hedge funds and large institutions have $12.8M invested in ALPS Medical Breakthroughs ETF in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 1

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

292% more capital invested

Capital invested by funds: $3.27M → $12.8M (+$9.57M)

38% more funds holding

Funds holding: 1318 (+5)

3.85% more ownership

Funds ownership: 6.63%10.48% (+3.9%)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

SBIO Hedge Fund Activity: Q2 2015 in Review

18 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2015, worth a combined $12.8M — up 292% from $3.27M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SBIO positions and 2 closed out — a net gain of 6 holders — while 9 added to existing stakes and 1 trimmed.

The largest buyer was LPL Financial, adding an estimated $2.55M. The largest seller was Royal Bank of Canada, cutting an estimated $451K.

  • 18 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2015, up from 13 in Q1 2015.
  • Funds reported $12.8M of ALPS Medical Breakthroughs ETF stock for Q2 2015, up 292% quarter-over-quarter.
  • 8 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2015 and 2 closed out, a net change of +6 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q2 2015 was LPL Financial, an estimated $2.55M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q2 2015 was Royal Bank of Canada, an estimated $451K sold.

Based on aggregated 13F filings for Q2 2015.